Objectives the aim of this study was to to compare lidocaine versus methyl salicylate patches in treatment of myofascial pain.Materials and methods: thirty patients sufferred from myofascial pain in head and neck muscles were divided randomly into three groups: Group one (10 patients): was treated with methyl salicylate patch. Group two (10 patients): was treated through lidocaine patch .Group three (10 patients): was acted as a controlled group through the application of plain patches without any active ingredient. Each patient has received one patch that had replaced by the patient every 12 hours; the patient informed to remove the last patch 12 hours before the visit on day five. All evaluations (pain intensity, degree of mouth opening, range of motion, disability) repeated on day five (12 hours after removal of the last patch) and on day nine (after four days of follow up). Results significant reduction in pain intensity, significant increase in mouth opening and lateral movement and significant improvement in quality of life with methyl salicylate and lidocaine patches. Conclusions Methyl salicylate and Lidocaine patches are effective in treatment of Myofascial pain
Published in | International Journal of Clinical Oral and Maxillofacial Surgery (Volume 1, Issue 2) |
DOI | 10.11648/j.ijcoms.20150102.13 |
Page(s) | 20-23 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2015. Published by Science Publishing Group |
Myofacial Pain, Methyl Salicylate Patches, Lidocaine Patches
[1] | Fricton J.R. Myofascial pain syndrome Neurol Clin, 1989; 7:413-427. |
[2] | Simons DG. Muscular pain syndromes. Advances in Pain Research and Therapy 1990; 17:1–41. |
[3] | Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. American Family Physician 2002; 65:653–60. |
[4] | Gerwin RD. Myofascial pain syndromes from trigger points. Current Review of Pain 1999; 3:153–9. |
[5] | Staud R. Future perspectives: pathogenesis of chronic muscle pain. Best Practice & Research Clinical Rheumatology 2007; 21:581–96. |
[6] | Heloe L.A., Hiberg, Heloe B., Heiberg A.N., , Magnus, P. Berg K., Nance W.E. Myofascial pain dysfunction (MPD) syndrome in twins Community Dent Oral Epidemiol, 1989; 8:434–436. |
[7] | Thiru Mandyam Annaswamy, Arthur J. De Luigi Bryan J. O'Neill Nandita Keole ) Emerging Concepts in the Treatment of Myofascial Pain: A Review of Medications, Modalities, and Needle-based Interventions. PM&R October 2011;Volume 3, Issue 10 , Pages 940-961 |
[8] | Wetzel D, Menke W, Dieter R, et al. Escin/diethylammonium salicylate/heparin combination gels for the topical treatment of acute impact injuries: A randomised, double blind, placebo controlled, multicentre study. Br J Sports Med. 2002; 36:183–188. |
[9] | Lobo SL, Mehta N, Forgione AG, et al. Use of Theraflex-TMJ topical cream for the treatment of temporomandibular joint and muscle pain. Cranio. 2004; 22:137–144. |
[10] | Mason L, Moore RA, Edwards JE, et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ. 2004; 328:995. |
[11] | Higashi Y, Kiuchi T, Furuta K. Efficacy and safety profile of a topical methyl salicylate and menthol patch in adult patients with mild to moderate muscle strain: a randomized, double-blind, parallel-group, placebo-controlled, multicenter study. Cli Ther. 2010 Jan; 32:34-43. |
[12] | Affaitati G, Fabrizio A, Savini A, et al. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: Evaluation of pain and somatic pain thresholds. Clin Ther 2009; 31:705-720. |
APA Style
Ahmed M. Atef, Mohammed A El- Sholkamy, Amr A. El-Swify, Eman A. El-Sharrawy. (2015). A Comparative Study Between Lidocaine and Methyl Salicylate Patches in Treatment of Myofascial Pain. International Journal of Clinical Oral and Maxillofacial Surgery, 1(2), 20-23. https://doi.org/10.11648/j.ijcoms.20150102.13
ACS Style
Ahmed M. Atef; Mohammed A El- Sholkamy; Amr A. El-Swify; Eman A. El-Sharrawy. A Comparative Study Between Lidocaine and Methyl Salicylate Patches in Treatment of Myofascial Pain. Int. J. Clin. Oral Maxillofac. Surg. 2015, 1(2), 20-23. doi: 10.11648/j.ijcoms.20150102.13
@article{10.11648/j.ijcoms.20150102.13, author = {Ahmed M. Atef and Mohammed A El- Sholkamy and Amr A. El-Swify and Eman A. El-Sharrawy}, title = {A Comparative Study Between Lidocaine and Methyl Salicylate Patches in Treatment of Myofascial Pain}, journal = {International Journal of Clinical Oral and Maxillofacial Surgery}, volume = {1}, number = {2}, pages = {20-23}, doi = {10.11648/j.ijcoms.20150102.13}, url = {https://doi.org/10.11648/j.ijcoms.20150102.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcoms.20150102.13}, abstract = {Objectives the aim of this study was to to compare lidocaine versus methyl salicylate patches in treatment of myofascial pain.Materials and methods: thirty patients sufferred from myofascial pain in head and neck muscles were divided randomly into three groups: Group one (10 patients): was treated with methyl salicylate patch. Group two (10 patients): was treated through lidocaine patch .Group three (10 patients): was acted as a controlled group through the application of plain patches without any active ingredient. Each patient has received one patch that had replaced by the patient every 12 hours; the patient informed to remove the last patch 12 hours before the visit on day five. All evaluations (pain intensity, degree of mouth opening, range of motion, disability) repeated on day five (12 hours after removal of the last patch) and on day nine (after four days of follow up). Results significant reduction in pain intensity, significant increase in mouth opening and lateral movement and significant improvement in quality of life with methyl salicylate and lidocaine patches. Conclusions Methyl salicylate and Lidocaine patches are effective in treatment of Myofascial pain}, year = {2015} }
TY - JOUR T1 - A Comparative Study Between Lidocaine and Methyl Salicylate Patches in Treatment of Myofascial Pain AU - Ahmed M. Atef AU - Mohammed A El- Sholkamy AU - Amr A. El-Swify AU - Eman A. El-Sharrawy Y1 - 2015/08/01 PY - 2015 N1 - https://doi.org/10.11648/j.ijcoms.20150102.13 DO - 10.11648/j.ijcoms.20150102.13 T2 - International Journal of Clinical Oral and Maxillofacial Surgery JF - International Journal of Clinical Oral and Maxillofacial Surgery JO - International Journal of Clinical Oral and Maxillofacial Surgery SP - 20 EP - 23 PB - Science Publishing Group SN - 2472-1344 UR - https://doi.org/10.11648/j.ijcoms.20150102.13 AB - Objectives the aim of this study was to to compare lidocaine versus methyl salicylate patches in treatment of myofascial pain.Materials and methods: thirty patients sufferred from myofascial pain in head and neck muscles were divided randomly into three groups: Group one (10 patients): was treated with methyl salicylate patch. Group two (10 patients): was treated through lidocaine patch .Group three (10 patients): was acted as a controlled group through the application of plain patches without any active ingredient. Each patient has received one patch that had replaced by the patient every 12 hours; the patient informed to remove the last patch 12 hours before the visit on day five. All evaluations (pain intensity, degree of mouth opening, range of motion, disability) repeated on day five (12 hours after removal of the last patch) and on day nine (after four days of follow up). Results significant reduction in pain intensity, significant increase in mouth opening and lateral movement and significant improvement in quality of life with methyl salicylate and lidocaine patches. Conclusions Methyl salicylate and Lidocaine patches are effective in treatment of Myofascial pain VL - 1 IS - 2 ER -